MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes

Shanliang Zhong; Xiu Chen; Dandan Wang; Xiaohui Zhang; Hongyu Shen; Sujin Yang; Mengmeng Lv; Jinhai Tang; Jianhua Zhao

doi:10.18632/oncotarget.7481

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes

Shanliang Zhong, Xiu Chen, Dandan Wang, Xiaohui Zhang, Hongyu Shen, Sujin Yang, Mengmeng Lv, Jinhai Tang and Jianhua Zhao _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:19601-19609. https://doi.org/10.18632/oncotarget.7481

Metrics: PDF 3865 views | HTML 4168 views | ?

Abstract

Shanliang Zhong1, Xiu Chen2, Dandan Wang2, Xiaohui Zhang1, Hongyu Shen2, Sujin Yang2, Mengmeng Lv2, Jinhai Tang2, Jianhua Zhao1

1Center of Clinical Laboratory Science, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China

2Department of General Surgery, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China

Correspondence to:

Jianhua Zhao, e-mail: [email protected], [email protected]

Keywords: microvesicles, breast, cancer, chemoresistance, microRNA

Received: December 02, 2015 Accepted: February 11, 2016 Published: February 18, 2016

ABSTRACT

Exosomes have been shown to transmit drug resistance through delivering miRNAs. We aimed to explore their roles in breast cancer. Three resistant sublines were established by exposing parental MDA-MB-231 cell line to docetaxel, epirubicin and vinorelbine, respectively. Preneoadjuvant chemotherapy biopsies and paired surgically-resected specimens embedded in paraffin from 23 breast cancer patients were collected. MiRNA expression profiles of the cell lines and their exosomes were evaluated using microarray. The result showed that most miRNAs in exosomes had a lower expression level than that in cells, however, some miRNAs expressed higher in exosomes than in cells, suggesting a number of miRNAs is concentrated in exosomes. Among the dysregulated miRNAs, 22 miRNAs were consistently up-regulated in exosomes and their cells of origin. We further found that 12 of the 22 miRNAs were significantly up-regulated after preneoadjuvant chemotherapy. Further study of the role of these 12 miRNAs in acquisition of drug resistance is needed to clarify their contribution to chemoresistance.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7481

Publication Alerts

Research Papers:

MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes

Abstract